Complex Generics Offer Obstacles, Opportunities
Absorption Systems’ COO, Vatsala Naageshwaran, sat down with Outsourcing Pharma to discuss the challenges and rewards associated with generic drugs and how to approach getting to market.
“Generic drugs compromise a significant chunk of pharmaceutical business – more than 80% of all drugs prescribed to US patients currently are generic products. However, getting such therapies in the hands of users can be challenging, especially for complex products.
Outsourcing-Pharma (OSP) recently talked with Vatsala Naageshwaran (VN), chief business officer for Absorption Systems, about the vital role of generic drugs play on the pharmaceutical landscape, and how to overcome the various challenges associated with bringing such drugs to market.”